Literature DB >> 20960176

Monocyte chemoattractant protein-1 (MCP-1) 2518G/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy.

M Karadeniz1, M Erdogan, Sevki Cetinkalp, A Berdeli, Z Eroglu, A G Ozgen.   

Abstract

Tissue macrophage accumulation is thought to induce insulin resistance during obesity and stimulate the progression of diabetic nephropathy (DN). The objective of this study was to investigate genotypic and allelic frequencies of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in the healthy and patients with and without DN. The MCP-1 genotypes were determined in 43 patients with nephropathy and 43 without nephropathy and a control group of 105 healthy individuals. The genotype MCP-1 (-2518G/A) distribution did differ between the control group and the type 2 diabetic patients (P = 0.004). The frequency of the polymorphic G allele was also no similar for the group with type 2 diabetes as for the control group with 20.9 and 32.4%, respectively (P = 0.012). The AA genotype and A allele at MCP-1 -2518 was an independent risk factor for the progression of type 2 diabetes. In conclusion, MCP-1 AA genotype and A allele may play a specific role(s) in determining diabetic susceptibility, but do not seem to be important in the clinical manifestations of DN.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960176     DOI: 10.1007/s12020-010-9342-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  19 in total

1.  Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.

Authors:  F Y Chow; D J Nikolic-Paterson; E Ozols; R C Atkins; B J Rollin; G H Tesch
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

2.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

3.  Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney.

Authors:  James C Rice; Jeff S Spence; Deborah L Yetman; Robert L Safirstein
Journal:  Ren Fail       Date:  2002-11       Impact factor: 2.606

4.  Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

Authors:  N Banba; T Nakamura; M Matsumura; H Kuroda; Y Hattori; K Kasai
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

5.  9HODE stimulates cell proliferation and extracellular matrix synthesis in human mesangial cells via PPARgamma.

Authors:  Mayumi Negishi; Hiroyuki Shimizu; Shuichi Okada; Atsushi Kuwabara; Fumikazu Okajima; Masatomo Mori
Journal:  Exp Biol Med (Maywood)       Date:  2004-11

6.  Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.

Authors:  F Y Chow; D J Nikolic-Paterson; F Y Ma; E Ozols; B J Rollins; G H Tesch
Journal:  Diabetologia       Date:  2006-12-12       Impact factor: 10.122

7.  A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation.

Authors:  Bernd Krüger; Bernd Schröppel; Rami Ashkan; Brad Marder; Carl Zülke; Barbara Murphy; Bernhard K Krämer; Michael Fischereder
Journal:  J Am Soc Nephrol       Date:  2002-10       Impact factor: 10.121

8.  Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity.

Authors:  Chris Baylis; Elke-Astrid Atzpodien; Gary Freshour; Kevin Engels
Journal:  J Pharmacol Exp Ther       Date:  2003-10-14       Impact factor: 4.030

9.  Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus.

Authors:  E Simeoni; M M Hoffmann; B R Winkelmann; J Ruiz; S Fleury; B O Boehm; W März; G Vassalli
Journal:  Diabetologia       Date:  2004-09-02       Impact factor: 10.122

Review 10.  Genetic factors in diabetic nephropathy.

Authors:  Barry I Freedman; Meredith Bostrom; Pirouz Daeihagh; Donald W Bowden
Journal:  Clin J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 8.237

View more
  10 in total

1.  Relationship between type 2 diabetes mellitus and a novel polymorphism C698T in C5L2 in the Chinese Han population.

Authors:  Ying-Ying Zheng; Xiang Xie; Yi-Tong Ma; Yi-Ning Yang; Zhen-Yan Fu; Xiao-Mei Li; Xiang Ma; Bang-Dang Chen; Fen Liu
Journal:  Endocrine       Date:  2011-12-18       Impact factor: 3.633

Review 2.  Lipid deposition and metaflammation in diabetic kidney disease.

Authors:  Alla Mitrofanova; Antonio M Fontanella; Sandra Merscher; Alessia Fornoni
Journal:  Curr Opin Pharmacol       Date:  2020-11-01       Impact factor: 5.547

Review 3.  Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.

Authors:  Jun Panee
Journal:  Cytokine       Date:  2012-07-04       Impact factor: 3.861

4.  The associations between the MCP-1 -2518 A/G polymorphism and ischemic heart disease and ischemic stroke: a meta-analysis of 28 research studies involving 21,524 individuals.

Authors:  Gaojun Cai; Bifeng Zhang; Weijin Weng; Ganwei Shi; Zhiying Huang
Journal:  Mol Biol Rep       Date:  2014-11-21       Impact factor: 2.316

5.  Association of acylation-stimulating protein and receptor gene polymorphisms with coronary heart disease in Han and Hui populations.

Authors:  Honglei Jiang; Xiangju Liu; Dong Wang; Fang Guo; Jidong Liu; Xiaotang Liang; Zhaoqin Xing; Chunlin Cao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome.

Authors:  Lan Li; Ji Eun Ryoo; Kyung-Ju Lee; Bum-Chae Choi; Kwang-Hyun Baek
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

7.  Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study.

Authors:  Priyanka Raina; Ruhi Sikka; Himanshu Gupta; Kawaljit Matharoo; Surinder Kumar Bali; Virinder Singh; Ajs Bhanwer
Journal:  Biochem Genet       Date:  2021-02-20       Impact factor: 1.890

8.  Monocyte chemoattractant protein-1 gene (MCP-1-2518 A/G) polymorphism and serological markers of hepatitis B virus infection in hemodialysis patients.

Authors:  Alicja E Grzegorzewska; Dominik Pajzderski; Anna Sowińska; Paweł P Jagodziński
Journal:  Med Sci Monit       Date:  2014-06-30

Review 9.  Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.

Authors:  Un Ju Jung; Myung-Sook Choi
Journal:  Int J Mol Sci       Date:  2014-04-11       Impact factor: 5.923

10.  Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy.

Authors:  Bashair M Mussa; Ankita Srivastava; Abeer Al-Habshi; Abdul Khader Mohammed; Rabih Halwani; Salah Abusnana
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-26       Impact factor: 3.168

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.